23 March 2026 - Top Stories
Coverage across health, digital health, funding, and policy developments in Australia.
Daily digest
17 articlesMethodology: This digest condenses the source coverage listed below for faster scanning by Australian health teams. It is not medical advice.
Healthdirect rebranded to 1800Medicare and AI front door tools plus vision-enabled scribes reshape how Australians access care.
AI front door tools are speeding patient triage and guiding care pathways, while vision-enabled scribes lift note accuracy and cut admin load. The shift increases demand for privacy by design and robust data governance as video data becomes part of clinical records.
Beamtree's precision health report flags costs, access hurdles and ethics as genomics becomes routine. It warns Indigenous and First Nations people risk exclusion unless data platforms improve representation and public trust. The conclusion favours systems investing in interoperable data foundations and community engagement.
Fragmentation in care pathways persists. The RACGP's support for 12 month referrals with safeguards pushes vendors to deliver interoperable referral tools and standard data exchanges to prevent care gaps and escalating costs.
Donanemab and Leqembi approvals give eligible patients access to disease-modifying therapy for early Alzheimer's, but GP monitoring and MRI capacity will be stressed as demand grows. Separately, RMIT's carbon-dot hydrogel wound patch enables real-time infection sensing and on-demand therapy release, yet regulatory clearance and cost hurdles will determine scaling.
NSW recorded 530 GP trainees in 2026, including 255 rural entrants, boosting regional care capacity but raising questions about long-term retention.
- Healthdirect rebranded to 1800Medicare and linked with patient AI tools, and Australian purchasers will demand privacy by design and interoperable data flows before adopting front door platforms.
- Vision-enabled AI scribes using Google Gemini and Meta glasses improved note accuracy to 98 percent in testing, prompting buyers to require strong data governance and privacy safeguards before widescale deployment.
- Donanemab and Leqembi approvals give eligible Australian patients access to disease-modifying therapy, which will stress GP triage and MRI capacity as demand grows.
- RMIT's carbon-dot hydrogel wound patch enables real-time infection sensing and on-demand therapy release, creating demand for regulatory clearance and cost effective adoption in clinics.
- RACGP backs 12 month referrals with safeguards, driving health IT demand for interoperable referral tools and standardized data exchanges to prevent care fragmentation.
- NSW recorded 530 GP trainees in 2026, including 255 rural entrants, boosting regional care capacity but raising questions about long-term retention.